Risk of gonadotoxicity with immunotherapy and targeted agents remains an unsolved but crucial issue
- PMID: 35342940
- DOI: 10.1111/eci.13779
Risk of gonadotoxicity with immunotherapy and targeted agents remains an unsolved but crucial issue
Keywords: breast cancer; immunotherapy; oncofertility; targeted agents.
Comment on
-
Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis.J Clin Oncol. 2021 Oct 10;39(29):3293-3305. doi: 10.1200/JCO.21.00535. Epub 2021 Jul 1. J Clin Oncol. 2021. PMID: 34197218
References
REFERENCES
-
- Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7-33.
-
- Lambertini M, Peccatori FA, Demeestere I, et al. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines†. Ann Oncol. 2020;31(12):1664-1678.
-
- Anderson RA, Amant F, ESHRE Guideline Group on Female Fertility Preservation, et al. ESHRE guideline: female fertility preservation. Hum Reprod Open. 2020;2020(4):hoaa052.
-
- Lambertini M, Di Maio M, Pagani O, et al. The BCY3/BCC 2017 survey on physicians’ knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients. Breast. 2018;22(42):41-49.
-
- Lambertini M, Blondeaux E, Bruzzone M, et al. Pregnancy after breast cancer: a systematic review and meta-analysis. J Clin Oncol. 2021;39(29):3293-3305.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical